Advanced search
Publication Cover
Vascular Health and Risk Management Volume 11, 2015 - Issue
Submit an article Journal homepage
85
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy

Anne H Blaes1 Division of Hematology/Oncology/Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USACorrespondence[email protected]
,
Aamer Rehman2 Division of Cardiology, University of Louisville, Louisville, KY, USA
,
David M Vock3 Masonic Cancer Center, University of Minnesota, Minneapolis, USA;4 Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, USA
,
Xianghua Luo3 Masonic Cancer Center, University of Minnesota, Minneapolis, USA;4 Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, USA
,
Mark Menge5 Park Nicollet Frauenshuh Cancer Center, St Louis Park, USA
,
Douglas Yee3 Masonic Cancer Center, University of Minnesota, Minneapolis, USA
,
Emil Missov6 Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
&
Daniel Duprez6 Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
 show all
Pages 591-594 | Published online: 24 Nov 2015

References

  • LenihanDJCardinaleDMLate cardiac effects of cancer treatmentJ Clin Oncol201230303657366423008297
  • McKillopJBristowMGorisMBillinghamMBockemuehlKSensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicityAm Heart J19831065 Pt 1104810566637763
  • LenihanDJCardinaleDCipollaCMThe compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology SocietyProg Cardiovasc Dis2010532889320728695
  • NeelandIJDraznerMHBerryJDBiomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general populationJ Am Coll Cardiol201361218719523219305
  • KalogeropoulosAPGeorgiopoulouVVdeFilippiCRGottdienerJSButlerJEchocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health StudyJACC Cardiovasc Imaging20125213114022340818
  • de AntonioMLuponJGalanAVilaJUrrutiaABayes-GenisACombined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failureAm Heart J2012163582182822607860
  • HsiehBPRogersAMNaBWuAHSchillerNBWhooleyMAPrevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul studyAm Heart J2009158467367919781430
  • DanielsLBLaughlinGACloptonPMaiselASBarrett-ConnorEMinimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo studyJ Am Coll Cardiol200852645045918672166
  • CardinaleDColomboASandriMTPrevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibitionCirculation2006114232474248117101852
  • ZetheliusBJohnstonNVengePTroponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort studyCirculation200611381071107816490824
  • LatiniRMassonSAnandISPrognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failureCirculation2007116111242124917698733
  • SawayaHSebagIAPlanaJCEarly detection and prediction of cardiotoxicity in chemotherapy-treated patientsAm J Cardiol201110791375138021371685
  • BoschXEsteveJSitgesMPrevention of chemotherapy-induced left ventricular dysfunction with enalapril and carvedilol: rationale and design of the OVERCOME trialJ Card Fail201117864364821807325
  • PituskinEHaykowskyMMackeyJRRationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research trial (MANTICORE 101 – breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRIBMC Cancer20111131821794114

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.